Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05432791 |
|---|---|
| Brief Title: | Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working |
| First Submitted : | June 22, 2022 |
| First Submitted that Met QC Criteria : | June 22, 2022 |
| First Posted : | June 27, 2022 |
| Last Update Submitted that Met QC Criteria : | May 11, 2024 |
| Last Update Posted : | May 14, 2024 (Estimate) |